Literature DB >> 19026559

Cell-specific and concentration-dependent actions of interleukin-1 in acute brain inflammation.

Emmanuel Pinteaux1, Paula Trotter, Anastasia Simi.   

Abstract

Interleukin (IL)-1 is a pivotal pro-inflammatory cytokine and an important mediator of both acute and chronic central nervous system (CNS) injuries. Despite intense research in CNS IL-1 biology over the past two decades, its precise mechanism of action in inflammatory responses to acute brain disorders remains largely unknown. In particular, much effort has been focussed on using in vitro approaches to better understand the cellular and signalling mechanisms of actions of IL-1, yet some discrepancies in the literature regarding the effects produced by IL-1beta in in vitro paradigms of injury still exist, particularly as to whether IL-1 exerts neurotoxic or neuroprotective effects. Here we aim to review the cell-specific and concentration-dependent actions of IL-1 in brain cells, to depict the mechanism by which this cytokine induces neurotoxicity or neuroprotection in acute brain injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19026559     DOI: 10.1016/j.cyto.2008.10.008

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  27 in total

1.  Synapse loss induced by interleukin-1β requires pre- and post-synaptic mechanisms.

Authors:  Anjuli Mishra; Hee Jung Kim; Angela H Shin; Stanley A Thayer
Journal:  J Neuroimmune Pharmacol       Date:  2012-02-05       Impact factor: 4.147

2.  The role of IL-1β in nicotine-induced immunosuppression and neuroimmune communication.

Authors:  Seddigheh Razani-Boroujerdi; Raymond J Langley; Shashi P Singh; Juan Carlos Pena-Philippides; Jules Rir-sima-ah; Sravanthi Gundavarapu; Neerad C Mishra; Mohan L Sopori
Journal:  J Neuroimmune Pharmacol       Date:  2011-06-14       Impact factor: 4.147

3.  Oxygen-glucose deprivation (OGD) and interleukin-1 (IL-1) differentially modulate cathepsin B/L mediated generation of neuroprotective perlecan LG3 by neurons.

Authors:  Maxim G Saini; Gregory J Bix
Journal:  Brain Res       Date:  2011-12-20       Impact factor: 3.252

4.  CXCR3 promotes plaque formation and behavioral deficits in an Alzheimer's disease model.

Authors:  Marius Krauthausen; Markus P Kummer; Julian Zimmermann; Elisabet Reyes-Irisarri; Dick Terwel; Bruno Bulic; Michael T Heneka; Marcus Müller
Journal:  J Clin Invest       Date:  2014-12-15       Impact factor: 14.808

5.  Interleukin-1 Receptor in Seizure Susceptibility after Traumatic Injury to the Pediatric Brain.

Authors:  Bridgette D Semple; Terence J O'Brien; Kayleen Gimlin; David K Wright; Shi Eun Kim; Pablo M Casillas-Espinosa; Kyria M Webster; Steven Petrou; Linda J Noble-Haeusslein
Journal:  J Neurosci       Date:  2017-07-19       Impact factor: 6.167

6.  Brain-derived neurotrophic factor-dependent synaptic plasticity is suppressed by interleukin-1β via p38 mitogen-activated protein kinase.

Authors:  Liqi Tong; G Aleph Prieto; Enikö A Kramár; Erica D Smith; David H Cribbs; Gary Lynch; Carl W Cotman
Journal:  J Neurosci       Date:  2012-12-05       Impact factor: 6.167

7.  Spatial contrast sensitivity vision loss in children with cortical visual impairment.

Authors:  William V Good; Chuan Hou; Anthony M Norcia
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-11-19       Impact factor: 4.799

8.  Pro-inflammatory cytokines derived from West Nile virus (WNV)-infected SK-N-SH cells mediate neuroinflammatory markers and neuronal death.

Authors:  Mukesh Kumar; Saguna Verma; Vivek R Nerurkar
Journal:  J Neuroinflammation       Date:  2010-10-31       Impact factor: 8.322

9.  Cell-Type-Specific Interleukin 1 Receptor 1 Signaling in the Brain Regulates Distinct Neuroimmune Activities.

Authors:  Xiaoyu Liu; Daniel P Nemeth; Daniel B McKim; Ling Zhu; Damon J DiSabato; Olimpia Berdysz; Gowthami Gorantla; Braedan Oliver; Kristina G Witcher; Yufen Wang; Christina E Negray; Rekha S Vegesna; John F Sheridan; Jonathan P Godbout; Matthew J Robson; Randy D Blakely; Phillip G Popovich; Staci D Bilbo; Ning Quan
Journal:  Immunity       Date:  2019-01-22       Impact factor: 31.745

10.  Does the administration of melatonin during post-traumatic brain injury affect cytokine levels?

Authors:  Fatemeh Dehghan; Nader Shahrokhi; Mohammad Khaksari; Zahra Soltani; Gholamreza Asadikorom; Ali Najafi; Nava Shahrokhi
Journal:  Inflammopharmacology       Date:  2017-11-20       Impact factor: 4.473

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.